IMPLANTABLE BIOELECTRONIC THERAPEUTICS
To tackle both neurological and metabolic disorders, we develop implantable systems that combine real-time sensing and targeted stimulation within a unified architecture. Engineered to interact with complex biological environments, these devices offer continuous, bidirectional communication with the body. By bridging the gap between detection and immediate treatment, our platforms pave the way for highly adaptive, closed-loop therapies.
WIRELESS NEUROMODULATION SYSTEMS
Neuromodulation systems, key to treating diverse neurological conditions, advance towards reducing invasiveness and increasing the ease of operation and patient comfort. Our work in this area integrates next-gen stimuli-responsive materials, soft electronics, and adaptive geometries to create implantable, minimally invasive platforms for targeted neural stimulation. We aim to enable power-efficient, wire-free neuromodulation strategies for rehabilitation and precision therapy.
ORGANOID-ELECTRODE ARCHITECTURES
By combining neural organoids with high-performance 3D microelectrode platforms (MEAs) we create physiologically relevant in vitro systems. The result: hybrid bioelectronic platforms that allow for real-time electrophysiological monitoring and serve as a tool for predictive analysis that can be used for neurological disease modelling, high-throughput drug evaluation, and validation of bioelectronic devices prior to in vivo studies.
NEXT-GENERATION NEUROINTERFACES
At ISESLab we leverage advanced biomaterials and conductive architectures to bridge biological neural tissue and electronic systems. With major focus on minimizing inflammatory response and maximizing signal fidelity, our next-generation interfaces aim to enable stable, long-term neural recording and stimulation for translational neurotechnologies
MINIMALLY INVASIVE AND
NON-INVASIVE SENSING
We develop advanced sensing platforms for minimally invasive and non-invasive biomedical monitoring. These technologies are designed to detect physiological signals and biochemical markers with high sensitivity and stability in complex biological environments. We also explore functional nanomaterials such as metal–organic frameworks (MOFs) for gas sensing, enabling the detection of volatile biomarkers and other clinically relevant analytes for diagnostic and health monitoring applications.
ABOUT US
The ISES Lab started in January 2026 and focuses on the engineering of smart bio-devices and the fundamental science that drives their development.
